Lyons, France

Claude Lardy

USPTO Granted Patents = 8 


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Lyon, FR (1999)
  • Lyons, FR (1995 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Claude Lardy: Innovator in Caspase-10 Inhibitors

Introduction

Claude Lardy is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of caspase-10 inhibitors. With a total of 8 patents to his name, Lardy's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Lardy's latest patents focus on specific caspase-10 inhibitors. The inventions relate to compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, i, and j have the meanings specified in the claims. These compounds are particularly aimed at treating diabetic retinopathy, showcasing Lardy's commitment to addressing critical health issues.

Career Highlights

Throughout his career, Claude Lardy has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent GmbH and Lyonnaise Industrielle Pharmaceutique. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities.

Collaborations

Lardy has collaborated with several professionals in his field, including Francois Collonges and Philippe Durbin. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Claude Lardy stands out as an influential inventor in the realm of pharmaceutical innovations. His work on caspase-10 inhibitors reflects his dedication to advancing medical treatments. Through his patents and collaborations, Lardy continues to make a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…